Pediatrics Doctors in Parkersburg, WV Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Miss Miniya Berhane, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 18th St, Suite 601, Parkersburg, WV 26101 Phone: 304-424-4106    Fax: 304-424-4108

Joan R Allman, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1907 Ann St, Parkersburg, WV 26101 Phone: 304-424-4205    Fax: 304-424-4485

Dr. Charles Frederic Whitaker Iii, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 600 18th St, Suite 304, Parkersburg, WV 26101 Phone: 304-424-4961    Fax: 304-424-4861

Cathy Anne Dailey, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3705 Emerson Ave, Parkersburg, WV 26104 Phone: 304-917-3530    Fax: 304-917-3743

Leigh Anna Meeks, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2107 Pike St Ste 6, Parkersburg, WV 26101 Phone: 304-865-5500    Fax: 304-865-5575

Dr. Russell A Miller, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1900c Garfield Ave, Parkersburg, WV 26101 Phone: 304-422-6682

Christopher T Miller, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 600 18th St, Suite 512, Parkersburg, WV 26101 Phone: 304-424-4574    Fax: 304-424-4429

Dr. Brett M. Wolfe, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 600 18th St, Suite 301, Parkersburg, WV 26101 Phone: 304-424-4677    Fax: 304-424-4679

News Archive

Global CRO PRA International achieves Rave Accredited Plus status in the ASPire to Win program

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that PRA International, a global clinical research organization (CRO), has achieved Rave Accredited Plus status in the ASPire to Win® program for CROs and other service providers.

AssureRx closes $12.5M Series C financing

AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.

Actavis, Scil Proteins sign Reteplase supply agreement

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.

Blue Shield of California refuses to pay for breast cancer drug Avastin

In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.

Read more Medical News

› Verified 7 days ago